Page last updated: 2024-08-18

isomethyleugenol and Benign Infratentorial Neoplasms

isomethyleugenol has been researched along with Benign Infratentorial Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acker, T; Becker, A; Brandner, S; Brokinkel, B; Buslei, R; Capper, D; Casalini, MB; Deckert, M; Dohmen, H; Ebrahimi, A; Felsberg, J; Fernández-Klett, F; Gramatzki, D; Hänggi, D; Hans, VH; Hartmann, C; Herold-Mende, C; Heß, K; Hewer, E; Huang, K; Jaunmuktane, Z; Jones, DTW; Koelsche, C; Korshunov, A; Mawrin, C; Paulus, W; Pfister, SM; Platten, M; Pohl, U; Prinz, M; Reifenberger, G; Reinhardt, A; Reuss, DE; Sahm, F; Schittenhelm, J; Schrimpf, D; Sievers, P; Staszewski, O; Stichel, D; Suwala, A; Unterberg, A; von Deimling, A; Wefers, AK; Weller, M; Wick, W1

Other Studies

1 other study(ies) available for isomethyleugenol and Benign Infratentorial Neoplasms

ArticleYear
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.
    Acta neuropathologica communications, 2019, 10-28, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cerebellar Neoplasms; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p16; ErbB Receptors; Female; Glioblastoma; Humans; Infant; Infant, Newborn; Infratentorial Neoplasms; Male; Methylation; Middle Aged; Retrospective Studies; Telomerase; Young Adult

2019